Erratum: Downregulation of heparanase by RNA interference inhibits invasion and tumorigenesis of hepatocellular cancer cells in vitro and in vivo (International Journal of Oncology (2012) 40 (1601-1609) DOI: 10.3892/ijo.2012.1338);Downregulation of heparanase by RNA interference inhibits invasion and tumorigenesis of hepatocellular cancer cells in vitro and in vivo

International Journal of Oncology

Volumn 40, Issue 5, 2012, Pages 1601-1609

  Xiong, Zhen ^a,b   Lü, Mu Han ^a   Fan, Ya Han ^a   Cao, Ya Ling ^a   Hu, Chang Jiang ^a   Wu, Yu Yun ^a,b   Wang, Shu Min ^a   Luo, Gang ^a   Fang, Dian Chun ^a   Li, Chuan ^a   Yang, Shi Ming ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b 181st Hospital of Chinese People Liberation Army   (China)

Author keywords

Heparanase; Invasion; Liver cancer; RNA interference; Small interfering RNA; Tumorigenesis

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; HEPARANASE; PLASMID VECTOR; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER GENE THERAPY; CANCER INVASION; CARCINOGENESIS; CARCINOGENICITY; CELL ASSAY; CELL CYCLE; CELL PROLIFERATION; CELL STRAIN HEPG2; CLONING VECTOR; CONTROLLED STUDY; DOWN REGULATION; DRUG TARGETING; FLOW CYTOMETRY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LIVER CANCER; LIVER CELL CARCINOMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA SEQUENCE; WESTERN BLOTTING;

EID: 84860303171     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2022.5315     Document Type: Erratum

References (31)

1. El-Serag HB and Mason AC: Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 340: 745-750, 1999. (Pubitemid 29114292)
2. Kubicka S, Rudolph KL, Hanke M, Tietze MK, Tillmann HL, Trautwein CE and Manns M: Hepatocellular carcinoma in Germany: a retrospective epidemiological study from a low-endemic area. Liver 20: 312-318, 2000. (Pubitemid 30488002)
3. Hulett MD, Freeman C, Hamdorf BJ, Baker RT, Harris MJ and Parish CR: Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis. Nat Med 5: 803-809, 1999. (Pubitemid 29318615)
4. Parish CR, Freeman C, Brown KJ, Francis DJ and Cowden WB: Identification of sulfated oligosaccharide-based inhibitors of tumor growth and metastasis using novel in vitro assays for angiogenesis and heparanase activity. Cancer Res 59: 3433-3441, 1999. (Pubitemid 29334505)
5. Toyoshima M and Nakajima M: Human heparanase: purification, characterization, cloning and expression. J Biol Chem 274: 24153-24160, 1999.
6. Vlodavsky I, Friedmann Y, Elkin M, Aingorn H, Atzmon R, Ishai-Michaeli R, Bitan M, Pappo O, Peretz T, Michal I, Spector L and Pecker I: Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis. Nat Med 5: 793-802, 1999. (Pubitemid 29318614)
7. Poste G and Fidler I: The pathogensis of cancer metastasis. Nature 283: 139-146, 1980.
8. Elkin M, Ilan N, Ishai-Michaeli R, Friedmann Y, Papo O, Pecker I and Vlodavsky I: Heparanase as mediator of angiogenesis: Mode of action. FASEB J 15: 1661-1663, 2001.
9. Kelly T, Miao HQ, Yang Y, Navarro E, Kussie P, Huang Y, MacLeod V, Casciano J, Joseph L, Zhan FH, Zangari M, Barlogie B, Shaughnessy J and Sanderson RA: High heparanase activity in multiple myeloma is associated with elevated microvessel density. Cancer Res 63: 8749-8756, 2003. (Pubitemid 38064053)
10. Cai YG, Fang DC, Yang SM, Luo YH, Yang MH and Wang DX: Increased expression of heparanase mRNA is correlated with metastasis of gastric carcinoma and is probably correlated with c-met protein. Zhonghua Yi Xue Za Zhi 84: 974-978, 2004.
11. McKenzie EA: Heparanase:a target for drug discovery in cancer and inflammation. Br J Pharmacol 151: 1-14, 2007.
12. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE and Mello CC: Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391: 806-811, 1998. (Pubitemid 28099681)
13. Fraser AG, Kamath RS, Zipperlen P, Martinez-Campos M, Sohrmann M and Ahringer J: Functional genomic analysis of C.elegans chromosome I by systematic RNA interference. Nature 408: 325-330, 2000.
14. Gonczy P, Echeverri C, Oegema K, Coulson A, Jones SJ, Copley RR, Duperon J, Oegema J, Brehm M, Cassin E, Hannak E, Kirkham M, Pichler S, Flohrs K, Goessen A, Leidel S, Alleaume AM, Martin C, Ozlu N, Bork P and Hyman AA: Functional genomic analysis of cell division in C. elegans using RNAi of genes on chromosome III. Nature 408: 331-336, 2000.
15. Kamath RS, Fraser AG, Dong Y, Poulin G, Durbin R, Gotta M, Kanapin A, Le Bot N, Moreno S, Sohrmann M, Welchman DP, Zipperlen P and Ahringer J: Systematic functional analysis of the Caenorhabditis elegans genome using RNAi. Nature 421: 231-237, 2003. (Pubitemid 36139121)
16. Yang SM, Fang DC, Yang JL, Chen L, Luo YH and Liang GP: Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro. Eur J Cancer Prev 17: 209-217, 2008. (Pubitemid 351549660)
17. Yu ST, Chen L, Wang HJ, Tang XD, Fang DC and Yang SM: hTERT promotes the invasion of telomerase-negative tumor cells in vitro. Int J Oncol 35: 329-336, 2009.
18. Zhang L, Sullivan P, Suyama J and Marchetti D: Epidermal growth factor-induced heparanase nucleolar localization augments DNA topoisomerase I activity in brain metastatic breast cancer. Mol Cancer Res 8: 278-290, 2010.
19. Tang XD, Wan Y, Chen L, Chen T, Yu ST, Xiong Z, Fang DC, Liang GP and Yang SM: H-2Kb-restricted CTL epitopes from mouse heparanase elicit an antitumor immune response in vivo. Cancer Res 68: 1529-1537, 2008. (Pubitemid 351346862)
20. Cohen I, Pappo O, Elkin M, San T, Bar-Shavit R, Hazan R, Peretz T, Vlodavsky I and Abramovitch R: Heparanase promotes growth, angiogenesis and survival of primary breast tumors. Int J Cancer 118: 1609-1617, 2006. (Pubitemid 43376422)
21. Chen G, Dang YW, Luo DZ, Feng ZB and Tang XL: Expression of heparanase in hepatocellular carcinoma has prognostic significance: a tissue microarray study. Oncol Res 17: 183-189, 2008.
22. Ferro V, Dredge K, Liu LG, Hammond E, Bytheway L, Li CP, Johnstone K, Karoli T, Davis K, Copeman E, Biotech B and Gautam A: PI-88 and novel heparan sulfate mimetics inhibit angiogenesis. Semin Thromb Hemost 33: 557-562, 2007. (Pubitemid 47105747)
23. Liu CJ, Lee PH, Lin DY, Wu CC, Jeng LB, Lin PW, Mok KT, Lee WC, Yeh HZ, Ho MC, Yang SS, Lee CC, Yu MC, Hu RH, Peng CY, Lai KL, Chang SSC and Chen PJ: Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage. J Hepatol 50: 958-968, 2009.
24. Edovitsky E, Elkin M, Zcharia E, Peretz and Vlodavsky I: Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis. J Natl Cancer Inst 96: 1219-1230, 2004. (Pubitemid 39232713)
25. Pederson T: RNA interference and mRNA silencing, 2004: how far will they reach. Mol Biol Cell 15: 407-410, 2004.
26. Zhang ZH, Chen Y, Zhao HJ, Xie CY, Ding J and Hou YT: Silencing of heparanase by siRNA inhibits tumor metastasis and angiogenesis of human breast cancer in vitro and in vivo. Cancer Biol Ther 6: 587-595, 2007. (Pubitemid 47328334)
27. Laursen LS, Overgaard MT, Weyer K, Boldt HB, Ebbsesn P, Christiansen M, Sorttrup-Jensen L, Giudice LC and Oxvig C: Cell surface targeting of pregnancy-associated plasma protein A proteolytic activity. Reversible adhesion is mediated by two neighboring short consensus repeats. J Biol Chem 277: 47225-47234, 2002. (Pubitemid 36159233)
28. Yasui K, Arii S, Zhao C, Imoto I, Ueda M, Nagai H, Emi M and Inazawa J: TFDP1, CUL4A, and CDC16 identified as targets for amplification at 13q34 in hepatocellular carcinomas. Hepatology 35: 1476-1484, 2002. (Pubitemid 34966902)
29. Duxbury MS and Whang EE: RNA interference: a practical approach. J Surg Res 117: 3339-3344, 2004.
30. Rubinson DA, Dillon CP, Kwiatkowski AV, Sievers C, Yang L, Kopinja J, Zhang MD, McManus MT, Gertler FB, Scott ML and Van Parijs L: A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat Genet 33: 401-406, 2003. (Pubitemid 36278858)
31. Holen T, Amarzguioui M, Wiiger MT, Babaie E and Prydz H: Positional effects of short interfering RNAs targeting the human coagulation trigger tissue factor. Nucl Acids Res 30: 1757-1766, 2002. (Pubitemid 34679753)